Top

Published in:

01-04-2022 | Confusion | IM - CASE RECORD

A man with hyponatremia, confusion, and involuntary limb movements

Authors: Gabriella Gruden, Sara Bernardi, Michela Scandella, Francesca Arietti, Giuseppe Gargiulo, Claudia Papa, Guglielmo Beccuti, Mario Giorgio Rizzone, Vincenzo Villari, Paolo Cavallo Perin, Marilena Durazzo

Published in: Internal and Emergency Medicine | Issue 3/2022

Excerpt

A 48-year-old Caucasian man presented to the Emergency Room with a 5-month history of involuntary movements of the limbs and confusion. …

Leypoldt F, Armangue T, Dalmau J (2015) Autoimmune encephalopathies. Ann N Y Acad Sci 1338:94–114. https://doi.org/10.1111/nyas.12553CrossRefPubMed

Petit-Pedrol M, Sell J, Planagumà J et al (2018) LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory. Brain 141:3144. https://doi.org/10.1093/brain/awy253CrossRefPubMedPubMedCentral

Whiles E, Joshi H, Prachi P, Kavuri V, Sagi SV (2020) Leucine-rich glioma-inactivated protein 1 (LGI1) mediated limbic encephalitis associated with syndrome of inappropriate antidiuretic hormone secretion: a case report. Oxf Med Case Rep. https://doi.org/10.1093/omcr/omz136CrossRef

van Sonderen A, Petit-Pedrol M, Dalmau J, Titulaer MJ (2017) The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol 13:290–301. https://doi.org/10.1038/nrneurol.2017.43CrossRefPubMed

van Sonderen A, Thijs RD, Coenders EC et al (2016) Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology 87:1449–1456. https://doi.org/10.1212/WNL.0000000000003173CrossRefPubMed

Messelmani M, Fekih-Mrissa N, Zaouali J, Mrissa R (2015) Limbic encephalitis associated with leucine-rich glioma-inactivated 1 antibodies. Ann Saudi Med 35:76–79. https://doi.org/10.5144/0256-4947.2015.76CrossRefPubMedPubMedCentral

van Sonderen A, Roelen DL, Stoop JA et al (2017) Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4. Ann Neurol 81:193–198. https://doi.org/10.1002/ana.24858CrossRefPubMed

Dalmau J, Graus F (2018) Antibody-mediated encephalitis. N Engl J Med 378:840–851. https://doi.org/10.1056/NEJMra1708712CrossRefPubMed

Hermetter C, Fazekas F, Hochmeister S (2018) Systematic review: syndromes, early diagnosis, and treatment in autoimmune encephalitis. Front Neurol 9:706. https://doi.org/10.3389/fneur.2018.00706CrossRefPubMedPubMedCentral

10.

de Bruijn MAAM, van Sonderen A, van Coevorden-Hameete MH et al (2019) Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA B R encephalitis. Neurology 92:e2185–e2196. https://doi.org/10.1212/WNL.0000000000007475CrossRefPubMedPubMedCentral

11.

Lancaster E (2016) The diagnosis and treatment of autoimmune encephalitis. J ClinNeurol 12:1–13. https://doi.org/10.3988/jcn.2016.12.1.1CrossRef

12.

Thompson J, Bi M, Murchison AG et al (2018) The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain 141:348–356. https://doi.org/10.1093/brain/awx323CrossRefPubMed

13.

Binks SNM, Klein CJ, Waters P et al (2018) LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. J NeurolNeurosurg Psychiatry 89:526–534. https://doi.org/10.1136/jnnp-2017-315720CrossRef

14.

Jarius S, Hoffmann L, Clover L et al (2008) CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis. J Neurol Sci 68:74–77. https://doi.org/10.1016/j.jns.2007.11.004CrossRef

15.

Zuliani L, Nosadini M, Gastaldi M et al (2019) Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations. Neurol Sci 40:2017–2030. https://doi.org/10.1007/s10072-019-03930-3CrossRefPubMed

16.

Liu X, Shan W, Zhao X et al (2020) The clinical value of 18 F-FDG-PET in autoimmune encephalitis associated with LGI1 antibody. Front Neurol 11:418. https://doi.org/10.3389/fneur.2020.00418CrossRefPubMedPubMedCentral

17.

Gadoth A, Pittock SJ, Dubey D et al (2017) Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients. Ann Neurol 82:79–92. https://doi.org/10.1002/ana.24979CrossRefPubMed

18.

Shin YW, Lee ST, Park KI et al (2017) Treatment strategies for autoimmune encephalitis. TherAdvNeurolDisord 11:1756285617722347. https://doi.org/10.1177/1756285617722347CrossRef

19.

Ariño H, Armangué T, Petit-Pedrol M et al (2016) Anti-LGI1-associated cognitive impairment: presentation and long-term outcome. Neurology 87:759. https://doi.org/10.1212/WNL.0000000000003009CrossRefPubMedPubMedCentral

Title: A man with hyponatremia, confusion, and involuntary limb movements
Authors: Gabriella Gruden
Sara Bernardi
Michela Scandella
Francesca Arietti
Giuseppe Gargiulo
Claudia Papa
Guglielmo Beccuti
Mario Giorgio Rizzone
Vincenzo Villari
Paolo Cavallo Perin
Marilena Durazzo
Publication date: 01-04-2022
Publisher: Springer International Publishing
Keywords: Confusion
Electroencephalography
Conversion Disorder
Autoimmune Encephalitis
Encephalitis
Hyponatremia
Syndrome of Inappropriate ADH Secretion
Published in: Internal and Emergency Medicine / Issue 3/2022
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-021-02716-w

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2022

Patient adherence and comprehension of take-home anticoagulant regimens prescribed at the emergency department: preliminary findings from a randomized controlled trial and implications for patient safety

Different rates of conjunctivitis in COVID-19 eastern and western hospitalized patients: a meta-analysis

Comparison of characteristics and outcomes of patients admitted to hospital with COVID-19 during wave 1 and wave 2 of the current pandemic

Rise and fall of troponin in the emergency department: do we overlook an important group at risk?

PaO2/FiO2 ratio forecasts COVID-19 patients’ outcome regardless of age: a cross-sectional, monocentric study

Echocardiographic changes in anorexia nervosa: a pathophysiological adaptation or a disease?

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage